Your browser doesn't support javascript.
loading
Effect of latanoprost on choroidal thickness in patients with newly diagnosed primary open-angle glaucoma.
Buyukmurat, Neslihan; Karadag, Erdi; Ozbek, Hanefi.
Afiliación
  • Buyukmurat N; Department of Administration, University of Health Sciences, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkiye.
  • Karadag E; Department of Administration, University of Health Sciences, Kartal Dr. Lutfi Kirdar City Hospital, Istanbul, Turkiye.
  • Ozbek H; Department of Medical School Administration, Izmir Bakircay University, Izmir, Turkiye.
North Clin Istanb ; 11(4): 271-276, 2024.
Article en En | MEDLINE | ID: mdl-39165701
ABSTRACT

OBJECTIVE:

The purpose of this study was to assess the influence of latanoprost on choroidal thickness in patients with newly diagnosed primary open-angle glaucoma using Swept-Source Optical Coherence Tomography (SS-OCT).

METHODS:

The retrospective, non-randomized study comprised 40 newly diagnosed primary open-angle glaucoma patients receiving latanoprost therapy (Group 1). Additionally, 40 age- and sex-matched healthy subjects served as the control group (Group 2). Using SS-OCT, measurements of subfoveal, horizontal temporal, and horizontal nasal quadrants choroidal thickness, as well as intraocular pressure (IOP) and retinal nerve fiber layer (RNFL) thickness values, were collected at baseline and after 1 month for both groups.

RESULTS:

The mean age was 39.8±4.15 years (range 18-45 years) in group 1 and 41.67±7.95 years (range 18-45 years) in group 2 (p>0.05). The mean choroidal thickness in the subfoveal area, horizontal temporal quadrant, and horizontal nasal quadrant prior to latanoprost therapy were 263.57±84.23 µm, 233.05±80.08 µm, and 219.52±83.28 µm in the group 1 whereas 278.9±93.88 µm, 243.8±73.37 µm and 209.85±92.92 µm in the group 2. After latanoprost therapy, the mean choroidal thickness in the subfoveal area, horizontal temporal quadrant, and horizontal nasal quadrant changed significantly to 299.77±41.29 µm, 269.9±43.80 µm, and 261.32±45.60 µm in the group 1 (p=0.02, p=0.016, and p=0.012, respectively) (Table 1). However, the mean choroidal thickness in the subfoveal area, horizontal temporal quadrant and horizontal nasal quadrant in group 2 changed not significant and was 279.25±103.37 µm, 246.42±87.07 µm and 203.62±106.74 µm, respectively (p=0.4, p=0.5 and p=0.9, respectively). The mean IOP decreased significantly in group 1 (p=0.000) but did not change significantly in group 2 (p=0.153). There was no difference in RNFL thickness values at baseline and 1 st month in group 1 and group 2 (p>0.05).

CONCLUSION:

Topical latanoprost may increase choroidal thickness. Swept Source-OCT may contribute to our understanding of the actions of latanoprost on choroidal thickness.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: North Clin Istanb Año: 2024 Tipo del documento: Article Pais de publicación: Turquía

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: North Clin Istanb Año: 2024 Tipo del documento: Article Pais de publicación: Turquía